uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Activated ERK1/2 and phosphorylated oestrogen receptor alpha are associated with improved breast cancer survival in women treated with tamoxifen.
Show others and affiliations
2006 (English)In: Eur J Cancer, ISSN 0959-8049, Vol. 42, no 8, 1104-12 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2006. Vol. 42, no 8, 1104-12 p.
Keyword [en]
Adult, Aged, Antineoplastic Agents; Hormonal/*therapeutic use, Breast Neoplasms/*drug therapy/mortality, Estrogen Receptor alpha/*metabolism, Female, Humans, In Situ Hybridization; Fluorescence, Middle Aged, Mitogen-Activated Protein Kinase 3/*metabolism, Phosphorylation, Receptor; erbB-2/metabolism, Survival Analysis, Tamoxifen/*therapeutic use
Identifiers
URN: urn:nbn:se:uu:diva-11036PubMedID: 16603346OAI: oai:DiVA.org:uu-11036DiVA: diva2:38804
Available from: 2007-05-14 Created: 2007-05-14 Last updated: 2011-01-11

Open Access in DiVA

No full text

Other links

PubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=16603346&dopt=Citation
By organisation
Department of Genetics and Pathology

Search outside of DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric score

pubmed
urn-nbn
Total: 337 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf